IDM CPD-Accredited Seminar: The S-Curve: Nurturing a ‘TB Therapeutics Engine’ at the IDM, UCT – From a Postdoc to a Pioneer

Dr. Vinayak Singh is a Chief Research Officer & a Principal Investigator at the Holistic Drug Discovery and Development (H3D) Centre, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town (UCT), South Africa. He is an Associate Member of the IDM, and has over ~20 years of experience in drug discovery research, with expertise in Microbiology, Biochemistry, and Microbial Genetics, Genomics, and Physiology, particularly concerning tuberculosis and Gram negative pathogens. He has identified and validated over 18 novel tuberculosis drug targets.